Global Chronic Idiopathic Constipation Drugs Market Growth 2018-2023

Global Chronic Idiopathic Constipation Drugs Market Growth 2018-2023

Category

Pharmaceuticals

Published Date

22nd Oct 2018

Pages

164

Choose License

Final Price

Chronic idiopathic constipation (CIC) is a health condition in which a person experiences chronic symptoms of constipation, yet no visible cause can be identified through standard diagnostic testing. The term idiopathic is used because it means there is no known cause. CIC includes symptoms of difficult, infrequent, or incomplete bowel movements.
Over the next five years, this report projects that Chronic Idiopathic Constipation (CIC) Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report covers the present scenario (with the base year being 2017) and the growth prospects of global Chronic Idiopathic Constipation (CIC) Drugs market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Idiopathic Constipation (CIC) Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, this report considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Lubiprostone
Linaclotide
Others
Segmentation by application:
Hospitals & Clinics
Ambulatory Surgical Centres
Long Term Care Centres
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Actavis
Chugai Pharmaceutical
Ferring International Center
Synergy Pharmaceuticals
Pfizer
GlaxoSmithKline
Roche Holding
Sanofi
Bayer
Salix Pharmaceuticals
Sucampo Pharmaceuticals
Ironwood Pharmaceuticals
Progenics Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Chronic Idiopathic Constipation (CIC) Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Chronic Idiopathic Constipation (CIC) Drugs market by identifying its various subsegments.
Focuses on the key global Chronic Idiopathic Constipation (CIC) Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Chronic Idiopathic Constipation (CIC) Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Chronic Idiopathic Constipation (CIC) Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption 2013-2023
2.1.2 Chronic Idiopathic Constipation (CIC) Drugs Consumption CAGR by Region
2.2 Chronic Idiopathic Constipation (CIC) Drugs Segment by Type
2.2.1 Lubiprostone
2.2.2 Linaclotide
2.2.3 Others
2.3 Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type
2.3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Type (2013-2018)
2.4 Chronic Idiopathic Constipation (CIC) Drugs Segment by Application
2.4.1 Hospitals & Clinics
2.4.2 Ambulatory Surgical Centres
2.4.3 Long Term Care Centres
2.4.4 Others
2.5 Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application
2.5.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Chronic Idiopathic Constipation (CIC) Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Application (2013-2018)

3 Global Chronic Idiopathic Constipation (CIC) Drugs by Players
3.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Players
3.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Players (2016-2018)
3.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Players (2016-2018)
3.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Players
3.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Players (2016-2018)
3.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Players
3.4 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Chronic Idiopathic Constipation (CIC) Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Chronic Idiopathic Constipation (CIC) Drugs by Regions
4.1 Chronic Idiopathic Constipation (CIC) Drugs by Regions
4.1.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Regions
4.1.2 Global Chronic Idiopathic Constipation (CIC) Drugs Value by Regions
4.2 Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth
4.3 APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth
4.4 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth
4.5 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth

5 Americas
5.1 Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries
5.1.1 Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018)
5.2 Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type
5.3 Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries
6.1.1 APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018)
6.2 APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type
6.3 APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Chronic Idiopathic Constipation (CIC) Drugs by Countries
7.1.1 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018)
7.2 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type
7.3 Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs by Countries
8.1.1 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type
8.3 Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Chronic Idiopathic Constipation (CIC) Drugs Distributors
10.3 Chronic Idiopathic Constipation (CIC) Drugs Customer

11 Global Chronic Idiopathic Constipation (CIC) Drugs Market Forecast
11.1 Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast (2018-2023)
11.2 Global Chronic Idiopathic Constipation (CIC) Drugs Forecast by Regions
11.2.1 Global Chronic Idiopathic Constipation (CIC) Drugs Forecast by Regions (2018-2023)
11.2.2 Global Chronic Idiopathic Constipation (CIC) Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Chronic Idiopathic Constipation (CIC) Drugs Forecast by Type
11.8 Global Chronic Idiopathic Constipation (CIC) Drugs Forecast by Application

12 Key Players Analysis
12.1 Actavis
12.1.1 Company Details
12.1.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.1.3 Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Actavis News
12.2 Chugai Pharmaceutical
12.2.1 Company Details
12.2.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.2.3 Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Chugai Pharmaceutical News
12.3 Ferring International Center
12.3.1 Company Details
12.3.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.3.3 Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Ferring International Center News
12.4 Synergy Pharmaceuticals
12.4.1 Company Details
12.4.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.4.3 Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Synergy Pharmaceuticals News
12.5 Pfizer
12.5.1 Company Details
12.5.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.5.3 Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Pfizer News
12.6 GlaxoSmithKline
12.6.1 Company Details
12.6.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.6.3 GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 GlaxoSmithKline News
12.7 Roche Holding
12.7.1 Company Details
12.7.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.7.3 Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Roche Holding News
12.8 Sanofi
12.8.1 Company Details
12.8.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.8.3 Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Sanofi News
12.9 Bayer
12.9.1 Company Details
12.9.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.9.3 Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Bayer News
12.10 Salix Pharmaceuticals
12.10.1 Company Details
12.10.2 Chronic Idiopathic Constipation (CIC) Drugs Product Offered
12.10.3 Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Salix Pharmaceuticals News
12.11 Sucampo Pharmaceuticals
12.12 Ironwood Pharmaceuticals
12.13 Progenics Pharmaceuticals

13 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Figure Picture of Chronic Idiopathic Constipation (CIC) Drugs_x000D_
Table Product Specifications of Chronic Idiopathic Constipation (CIC) Drugs_x000D_
Figure Chronic Idiopathic Constipation (CIC) Drugs Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth Rate 2013-2023 (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Value Growth Rate 2013-2023 ($ Millions)_x000D_
Table Chronic Idiopathic Constipation (CIC) Drugs Consumption CAGR by Region 2013-2023 ($ Millions)_x000D_
Figure Product Picture of Lubiprostone_x000D_
Table Major Players of Lubiprostone_x000D_
Figure Product Picture of Linaclotide_x000D_
Table Major Players of Linaclotide_x000D_
Figure Product Picture of Others_x000D_
Table Major Players of Others_x000D_
Table Global Consumption Sales by Type (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Type (2013-2018) ($ million)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Type (2013-2018) ($ Millions)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Type (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Type (2013-2018)_x000D_
Figure Chronic Idiopathic Constipation (CIC) Drugs Consumed in Hospitals & Clinics_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Hospitals & Clinics (2013-2018) (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Hospitals & Clinics (2013-2018) ($ Millions)_x000D_
Figure Global Hospitals & Clinics YoY Growth ($ Millions)_x000D_
Figure Chronic Idiopathic Constipation (CIC) Drugs Consumed in Ambulatory Surgical Centres_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Ambulatory Surgical Centres (2013-2018) (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Ambulatory Surgical Centres (2013-2018) ($ Millions)_x000D_
Figure Global Ambulatory Surgical Centres YoY Growth ($ Millions)_x000D_
Figure Chronic Idiopathic Constipation (CIC) Drugs Consumed in Long Term Care Centres_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Long Term Care Centres (2013-2018) (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Long Term Care Centres (2013-2018) ($ Millions)_x000D_
Figure Global Long Term Care Centres YoY Growth ($ Millions)_x000D_
Figure Chronic Idiopathic Constipation (CIC) Drugs Consumed in Others_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Others (2013-2018) (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Market: Others (2013-2018) ($ Millions)_x000D_
Figure Global Others YoY Growth ($ Millions)_x000D_
Table Global Consumption Sales by Application (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value by Application (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Application (2013-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Application (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Application (2013-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales by Players (2016-2018) (K Units)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Players (2016-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Players in 2016_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sales Market Share by Players in 2017_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Players (2016-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Players in 2016_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Revenue Market Share by Players in 2017_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Players (2016-2018)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Sale Price by Players in 2017_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Manufacturing Base Distribution and Sales Area by Players_x000D_
Table Players Chronic Idiopathic Constipation (CIC) Drugs Products Offered_x000D_
Table Chronic Idiopathic Constipation (CIC) Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption by Regions 2013-2018 (K Units)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Regions 2013-2018_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Regions 2013-2018_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value by Regions 2013-2018 ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Regions 2013-2018_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Regions 2013-2018_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption 2013-2018 (K Units)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Value 2013-2018 ($ Millions)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption 2013-2018 (K Units)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Value 2013-2018 ($ Millions)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption 2013-2018 (K Units)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Value 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption 2013-2018 (K Units)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value 2013-2018 ($ Millions)_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018) (K Units)_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries in 2017_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries in 2017_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type (2013-2018) (K Units)_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type in 2017_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application (2013-2018) (K Units)_x000D_
Table Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application in 2017_x000D_
Figure United States Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure United States Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018) (K Units)_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries in 2017_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries in 2017_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type (2013-2018) (K Units)_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type in 2017_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application (2013-2018) (K Units)_x000D_
Table APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application in 2017_x000D_
Figure China Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure China Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure India Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure India Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018) (K Units)_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries in 2017_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries in 2017_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type (2013-2018) (K Units)_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type in 2017_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application (2013-2018) (K Units)_x000D_
Table Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application in 2017_x000D_
Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure France Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure France Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure UK Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure UK Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Spain Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Spain Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Countries (2013-2018) (K Units)_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Countries in 2017_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value Market Share by Countries in 2017_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Type (2013-2018) (K Units)_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Type in 2017_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption by Application (2013-2018) (K Units)_x000D_
Table Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share by Application in 2017_x000D_
Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Israel Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Israel Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth 2013-2018 (K Units)_x000D_
Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Chronic Idiopathic Constipation (CIC) Drugs Distributors List_x000D_
Table Chronic Idiopathic Constipation (CIC) Drugs Customer List_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)_x000D_
Figure Global Chronic Idiopathic Constipation (CIC) Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Countries (2018-2023) (K Units)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Forecast by Regions_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Forecast by Countries (2018-2023) ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share Forecast by Regions_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Americas Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure APAC Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Europe Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Middle East & Africa Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure United States Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure United States Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Canada Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Mexico Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Brazil Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Brazil Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure China Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure China Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Japan Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Korea Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Southeast Asia Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure India Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure India Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Australia Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Germany Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure France Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure France Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure UK Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure UK Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Italy Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Russia Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Spain Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Spain Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Egypt Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure South Africa Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Israel Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Israel Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure Turkey Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Consumption 2018-2023 (K Units)_x000D_
Figure GCC Countries Chronic Idiopathic Constipation (CIC) Drugs Value 2018-2023 ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Type (2018-2023) (K Units)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share Forecast by Type (2018-2023)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share Forecast by Type (2018-2023)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Forecast by Application (2018-2023) (K Units)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Consumption Market Share Forecast by Application (2018-2023)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global Chronic Idiopathic Constipation (CIC) Drugs Value Market Share Forecast by Application (2018-2023)_x000D_
Table Actavis Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Actavis Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Actavis Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Chugai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Chugai Pharmaceutical Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Ferring International Center Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Ferring International Center Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Synergy Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Synergy Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Pfizer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Pfizer Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure GlaxoSmithKline Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Roche Holding Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Roche Holding Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Sanofi Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Sanofi Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Bayer Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Bayer Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Salix Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Salix Pharmaceuticals Chronic Idiopathic Constipation (CIC) Drugs Market Share (2016-2018)_x000D_
Table Sucampo Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Ironwood Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us